Journal article 1441 views
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention
New England Journal of Medicine, Volume: 367, Issue: 1, Pages: 40 - 49
Swansea University Author: Ronan Lyons
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1056/NEJMoa1109617
Abstract
BACKGROUNDThe results of meta-analyses examining the relationship between vitamin D supplementationand fracture reduction have been inconsistent.METHODSWe pooled participant-level data from 11 double-blind, randomized, controlled trialsof oral vitamin D supplementation (daily, weekly, or every 4 mon...
Published in: | New England Journal of Medicine |
---|---|
ISSN: | 0028-4793 1533-4406 |
Published: |
2012
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa13315 |
first_indexed |
2013-07-23T12:09:59Z |
---|---|
last_indexed |
2018-02-09T04:44:00Z |
id |
cronfa13315 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2015-12-08T11:01:04.4460358</datestamp><bib-version>v2</bib-version><id>13315</id><entry>2012-11-20</entry><title>A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention</title><swanseaauthors><author><sid>83efcf2a9dfcf8b55586999d3d152ac6</sid><ORCID>0000-0001-5225-000X</ORCID><firstname>Ronan</firstname><surname>Lyons</surname><name>Ronan Lyons</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2012-11-20</date><deptcode>MEDS</deptcode><abstract>BACKGROUNDThe results of meta-analyses examining the relationship between vitamin D supplementationand fracture reduction have been inconsistent.METHODSWe pooled participant-level data from 11 double-blind, randomized, controlled trialsof oral vitamin D supplementation (daily, weekly, or every 4 months), with or withoutcalcium, as compared with placebo or calcium alone in persons 65 years of age orolder. Primary end points were the incidence of hip and any nonvertebral fracturesaccording to Cox regression analyses, with adjustment for age group, sex, type ofdwelling, and study. Our primary aim was to compare data from quartiles of actualintake of vitamin D (including each individual participant’s adherence to thetreatment and supplement use outside the study protocol) in the treatment groupsof all trials with data from the control groups.RESULTSWe included 31,022 persons (mean age, 76 years; 91% women) with 1111 incident hipfractures and 3770 nonvertebral fractures. Participants who were randomly assignedto receive vitamin D, as compared with those assigned to control groups, had anonsignificant 10% reduction in the risk of hip fracture (hazard ratio, 0.90; 95%confidence interval [CI], 0.80 to 1.01) and a 7% reduction in the risk of nonvertebralfracture (hazard ratio, 0.93; 95% CI, 0.87 to 0.99). By quartiles of actual intake,reduction in the risk of fracture was shown only at the highest intake level (median,800 IU daily; range, 792 to 2000), with a 30% reduction in the risk of hip fracture(hazard ratio, 0.70; 95% CI, 0.58 to 0.86) and a 14% reduction in the risk of any nonvertebralfracture (hazard ratio, 0.86; 95% CI, 0.76 to 0.96). Benefits at the highestlevel of vitamin D intake were fairly consistent across subgroups defined by age group,type of dwelling, baseline 25-hydroxyvitamin D level, and additional calcium intake.CONCLUSIONSHigh-dose vitamin D supplementation (!800 IU daily) was somewhat favorable inthe prevention of hip fracture and any nonvertebral fracture in persons 65 years ofage or older.</abstract><type>Journal Article</type><journal>New England Journal of Medicine</journal><volume>367</volume><journalNumber>1</journalNumber><paginationStart>40</paginationStart><paginationEnd>49</paginationEnd><publisher/><issnPrint>0028-4793</issnPrint><issnElectronic>1533-4406</issnElectronic><keywords>Fracture; Vitamin D; Prevention; Older People</keywords><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2012</publishedYear><publishedDate>2012-12-31</publishedDate><doi>10.1056/NEJMoa1109617</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2015-12-08T11:01:04.4460358</lastEdited><Created>2012-11-20T08:47:30.3817630</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Heike A</firstname><surname>Bischoff-Ferrari</surname><order>1</order></author><author><firstname>Walter C</firstname><surname>Willett</surname><order>2</order></author><author><firstname>Endel J</firstname><surname>Orav</surname><order>3</order></author><author><firstname>Paul</firstname><surname>Lips</surname><order>4</order></author><author><firstname>Pierre J</firstname><surname>Meunier</surname><order>5</order></author><author><firstname>Ronan</firstname><surname>Lyons</surname><orcid>0000-0001-5225-000X</orcid><order>6</order></author><author><firstname>Leon</firstname><surname>Flicker</surname><order>7</order></author><author><firstname>John</firstname><surname>Wark</surname><order>8</order></author><author><firstname>Rebecca D</firstname><surname>Jackson</surname><order>9</order></author><author><firstname>Jane A</firstname><surname>Cauley</surname><order>10</order></author><author><firstname>Haakon E</firstname><surname>Meyer</surname><order>11</order></author><author><firstname>Michael</firstname><surname>Pfeifer</surname><order>12</order></author><author><firstname>Kerrie M</firstname><surname>Sanders</surname><order>13</order></author><author><firstname>Hannes B</firstname><surname>Stähelin</surname><order>14</order></author><author><firstname>Robert</firstname><surname>Theiler</surname><order>15</order></author><author><firstname>Bess</firstname><surname>Dawson-Hughes</surname><order>16</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2015-12-08T11:01:04.4460358 v2 13315 2012-11-20 A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention 83efcf2a9dfcf8b55586999d3d152ac6 0000-0001-5225-000X Ronan Lyons Ronan Lyons true false 2012-11-20 MEDS BACKGROUNDThe results of meta-analyses examining the relationship between vitamin D supplementationand fracture reduction have been inconsistent.METHODSWe pooled participant-level data from 11 double-blind, randomized, controlled trialsof oral vitamin D supplementation (daily, weekly, or every 4 months), with or withoutcalcium, as compared with placebo or calcium alone in persons 65 years of age orolder. Primary end points were the incidence of hip and any nonvertebral fracturesaccording to Cox regression analyses, with adjustment for age group, sex, type ofdwelling, and study. Our primary aim was to compare data from quartiles of actualintake of vitamin D (including each individual participant’s adherence to thetreatment and supplement use outside the study protocol) in the treatment groupsof all trials with data from the control groups.RESULTSWe included 31,022 persons (mean age, 76 years; 91% women) with 1111 incident hipfractures and 3770 nonvertebral fractures. Participants who were randomly assignedto receive vitamin D, as compared with those assigned to control groups, had anonsignificant 10% reduction in the risk of hip fracture (hazard ratio, 0.90; 95%confidence interval [CI], 0.80 to 1.01) and a 7% reduction in the risk of nonvertebralfracture (hazard ratio, 0.93; 95% CI, 0.87 to 0.99). By quartiles of actual intake,reduction in the risk of fracture was shown only at the highest intake level (median,800 IU daily; range, 792 to 2000), with a 30% reduction in the risk of hip fracture(hazard ratio, 0.70; 95% CI, 0.58 to 0.86) and a 14% reduction in the risk of any nonvertebralfracture (hazard ratio, 0.86; 95% CI, 0.76 to 0.96). Benefits at the highestlevel of vitamin D intake were fairly consistent across subgroups defined by age group,type of dwelling, baseline 25-hydroxyvitamin D level, and additional calcium intake.CONCLUSIONSHigh-dose vitamin D supplementation (!800 IU daily) was somewhat favorable inthe prevention of hip fracture and any nonvertebral fracture in persons 65 years ofage or older. Journal Article New England Journal of Medicine 367 1 40 49 0028-4793 1533-4406 Fracture; Vitamin D; Prevention; Older People 31 12 2012 2012-12-31 10.1056/NEJMoa1109617 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2015-12-08T11:01:04.4460358 2012-11-20T08:47:30.3817630 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Heike A Bischoff-Ferrari 1 Walter C Willett 2 Endel J Orav 3 Paul Lips 4 Pierre J Meunier 5 Ronan Lyons 0000-0001-5225-000X 6 Leon Flicker 7 John Wark 8 Rebecca D Jackson 9 Jane A Cauley 10 Haakon E Meyer 11 Michael Pfeifer 12 Kerrie M Sanders 13 Hannes B Stähelin 14 Robert Theiler 15 Bess Dawson-Hughes 16 |
title |
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention |
spellingShingle |
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention Ronan Lyons |
title_short |
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention |
title_full |
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention |
title_fullStr |
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention |
title_full_unstemmed |
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention |
title_sort |
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention |
author_id_str_mv |
83efcf2a9dfcf8b55586999d3d152ac6 |
author_id_fullname_str_mv |
83efcf2a9dfcf8b55586999d3d152ac6_***_Ronan Lyons |
author |
Ronan Lyons |
author2 |
Heike A Bischoff-Ferrari Walter C Willett Endel J Orav Paul Lips Pierre J Meunier Ronan Lyons Leon Flicker John Wark Rebecca D Jackson Jane A Cauley Haakon E Meyer Michael Pfeifer Kerrie M Sanders Hannes B Stähelin Robert Theiler Bess Dawson-Hughes |
format |
Journal article |
container_title |
New England Journal of Medicine |
container_volume |
367 |
container_issue |
1 |
container_start_page |
40 |
publishDate |
2012 |
institution |
Swansea University |
issn |
0028-4793 1533-4406 |
doi_str_mv |
10.1056/NEJMoa1109617 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
description |
BACKGROUNDThe results of meta-analyses examining the relationship between vitamin D supplementationand fracture reduction have been inconsistent.METHODSWe pooled participant-level data from 11 double-blind, randomized, controlled trialsof oral vitamin D supplementation (daily, weekly, or every 4 months), with or withoutcalcium, as compared with placebo or calcium alone in persons 65 years of age orolder. Primary end points were the incidence of hip and any nonvertebral fracturesaccording to Cox regression analyses, with adjustment for age group, sex, type ofdwelling, and study. Our primary aim was to compare data from quartiles of actualintake of vitamin D (including each individual participant’s adherence to thetreatment and supplement use outside the study protocol) in the treatment groupsof all trials with data from the control groups.RESULTSWe included 31,022 persons (mean age, 76 years; 91% women) with 1111 incident hipfractures and 3770 nonvertebral fractures. Participants who were randomly assignedto receive vitamin D, as compared with those assigned to control groups, had anonsignificant 10% reduction in the risk of hip fracture (hazard ratio, 0.90; 95%confidence interval [CI], 0.80 to 1.01) and a 7% reduction in the risk of nonvertebralfracture (hazard ratio, 0.93; 95% CI, 0.87 to 0.99). By quartiles of actual intake,reduction in the risk of fracture was shown only at the highest intake level (median,800 IU daily; range, 792 to 2000), with a 30% reduction in the risk of hip fracture(hazard ratio, 0.70; 95% CI, 0.58 to 0.86) and a 14% reduction in the risk of any nonvertebralfracture (hazard ratio, 0.86; 95% CI, 0.76 to 0.96). Benefits at the highestlevel of vitamin D intake were fairly consistent across subgroups defined by age group,type of dwelling, baseline 25-hydroxyvitamin D level, and additional calcium intake.CONCLUSIONSHigh-dose vitamin D supplementation (!800 IU daily) was somewhat favorable inthe prevention of hip fracture and any nonvertebral fracture in persons 65 years ofage or older. |
published_date |
2012-12-31T06:26:36Z |
_version_ |
1821929317971525632 |
score |
11.048064 |